Immuneering Corp. (IMRX)
6.235
-0.28
(-4.37%)
USD |
NASDAQ |
Dec 09, 16:00
6.35
+0.12
(+1.84%)
After-Hours: 20:00
Immuneering Market Cap: 402.59M for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 168.99B |
| Alnylam Pharmaceuticals, Inc. | 54.85B |
| Regeneron Pharmaceuticals, Inc. | 72.79B |
| Fortress Biotech, Inc. | 88.46M |
| BridgeBio Pharma, Inc. | 13.81B |
Market Cap Related Metrics
| Price to Book Value | 1.766 |
| Price | 6.235 |
| Earnings Yield | -28.60% |